| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/21/1998 | CN1170716A Di-ortho substituted benzoyl guanidine, its preparing method, use and medicine containing them |
| 01/21/1998 | CN1170583A Health tea with function of made from ginkgo leaf, lotus leaf and persimmon leaf |
| 01/20/1998 | US5710272 Increasing cerebral blood flow |
| 01/20/1998 | US5710259 Treating congestive heart failure |
| 01/20/1998 | US5710169 Therapeutic heterocycles |
| 01/20/1998 | US5710167 Hydroxamic acid derivatives with tricyclic substitution for treating degenerative joint diseases |
| 01/20/1998 | US5710164 Diheterocyclic styryl nitriles |
| 01/20/1998 | US5710149 Piperazine derivatives as 5-ht antagonists |
| 01/20/1998 | US5710142 Vitamin D analogues |
| 01/20/1998 | US5710139 Heterocyclic compounds |
| 01/20/1998 | US5710136 Inhibition of neovascularization using VEGF-specific oligonucleotides |
| 01/20/1998 | US5710035 Human elastase IV |
| 01/20/1998 | US5710024 Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| 01/20/1998 | US5709867 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/20/1998 | CA2059000C Fused-ring aryl substituted imidazoles |
| 01/19/1998 | CA2210613A1 N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use |
| 01/15/1998 | WO1998001426A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 01/15/1998 | WO1998001159A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1998001143A1 Use of artichoke (cynara) extracts |
| 01/15/1998 | CA2257563A1 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | CA2207141A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/15/1998 | CA2207083A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/14/1998 | EP0818449A1 2-(1H)-quinolone derivatives as antagonists of excitatory amino acids |
| 01/14/1998 | EP0818448A1 Cycloalkano-pyridine as CETP inhibitors |
| 01/14/1998 | EP0818447A1 6-(Hydroxymethyl-ethyl)pyridines as HMG-CoA-reductase inhibitors |
| 01/14/1998 | EP0818197A1 Heterocyclic condensed pyridines as CETP inhibitors |
| 01/14/1998 | EP0817967A1 Insulin mimetic and enhancer assay |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817791A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 01/14/1998 | EP0817782A1 Phenyl derivatives useful as endothelin receptor antagonists |
| 01/14/1998 | EP0817770A1 Nonpeptides as tachykinin antagonists |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817642A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
| 01/14/1998 | EP0817638A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/14/1998 | EP0817627A1 Protein kinase c inhibitors |
| 01/14/1998 | EP0817622A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0662950B1 Benzenealkanoic acids for cardiovascular diseases |
| 01/14/1998 | EP0660832B1 Serotonin receptor agents |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | CN1170414A Human neutrophil elastase inhibitors |
| 01/14/1998 | CN1170407A Sulfonamides |
| 01/14/1998 | CN1170405A Aryl-and hetaryl-sulfonamide derivatives, their perparation and their use as endothelin antagonists |
| 01/14/1998 | CN1170402A Nitro-benzamides useful as anti-arrhythmic agents |
| 01/14/1998 | CN1169994A Xanthine compounds having terminally aminated alkynol side chains |
| 01/14/1998 | CN1169993A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof |
| 01/14/1998 | CN1169987A Ortho-substituen benzoyl guanidine, its preparation, use and mecdicines containing it |
| 01/14/1998 | CN1169986A 2.9-diamino-and 2-amino-8-carbamoyl-4-hydroxy-aldanoic acid amide derivatives |
| 01/13/1998 | US5708174 Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists |
| 01/13/1998 | US5708147 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 01/13/1998 | US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/13/1998 | US5708015 Method for using pharmaceutical compositions containing 2-(2-alkyphenyl-amino)-thiazolines as adrenergic agents |
| 01/13/1998 | US5708011 Use of levobupivacaine in a patient having depressed myocardial contractility |
| 01/13/1998 | US5708003 Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
| 01/13/1998 | US5707989 Pyrimido 5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 01/13/1998 | US5707970 Treatment of atheriosclerosis and as nutrients formed by reaction of arginine, silicate salt and inositol |
| 01/13/1998 | US5707815 Polypeptides produced bby expression of heterologous nucleic acid in cells and encoded by dna and hybridize |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/11/1998 | CA2209776A1 New derivatives of 2-(1h)-quinoline, their preparation and pharmaceutical compositions containing them |
| 01/08/1998 | WO1998000411A1 Prenyl transferase inhibitors |
| 01/08/1998 | WO1998000409A1 Inhibitors of prenyl transferases |
| 01/08/1998 | WO1998000405A1 Pharmaceutical preparation |
| 01/08/1998 | WO1998000395A1 Phenylalamine derivatives as integrin inhibitors |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | DE19627376A1 Verwendung von Artischocken-(Cynara)-Extrakten Use of artichoke (Cynara) extracts |
| 01/08/1998 | DE19624154A1 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung Ring Anne lined dihydropyrans, methods of preparation and their use |
| 01/08/1998 | CA2259224A1 Phenylalamine derivatives as integrin inhibitors |
| 01/08/1998 | CA2257948A1 Antiarrhythmic combinations of selective iks antagonists with beta-adenergic blocking agents |
| 01/08/1998 | CA2255893A1 Prenyl transferase inhibitors |
| 01/08/1998 | CA2209609A1 Bicyclic-fused pyridines |
| 01/08/1998 | CA2209550A1 6-(hydroxymethyl-ethyl)pyridines |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816357A1 Substituted indazole derivatives |
| 01/07/1998 | EP0815859A1 Intimal thickening inhibitors |
| 01/07/1998 | EP0815446A1 Method of identifying molecules that regulate fgf activity |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815239A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy |
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815228A2 Cellubrevin homologs |
| 01/07/1998 | EP0815221A1 A novel growth factor and a genetic sequence encoding same |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815127A1 Fucopeptides |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0815123A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
| 01/07/1998 | EP0815120A1 17-difluoromethylene-oestratrienes |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0815080A1 Di-substituted 1,4-piperidine esters and amides having 5-ht 4? antagonistic activity |
| 01/07/1998 | EP0814827A1 Vascular endothelial growth factor-b |
| 01/07/1998 | EP0814823A1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 01/07/1998 | EP0814810A1 Adenosine as a positive inotrop in the compromised heart |
| 01/07/1998 | EP0814801A2 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs |
| 01/07/1998 | EP0814800A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 01/07/1998 | EP0814799A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814791A1 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 01/07/1998 | EP0814775A1 Method and kit for preventing erectile dysfunction |
| 01/07/1998 | EP0716609A4 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF--g(b) ACTIVITY |
| 01/07/1998 | EP0703910B1 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |